Related Experiment Video
Updated: Nov 9, 2025
04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
12.3K
Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
Weiguo Fan1,2, Natalie J Torok1,2
1Division of Gastroenterology and HepatologyStanford UniversityStanfordCAUSA.
Hepatology Communications
|April 16, 2021
Abstract:
This is an editorial about non-invasive fibrosis markers in patients with NASH and type 2 diabetes mellitus.
More Related Videos
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
277
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
277
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
305
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
305